GeneBioTech Co. Ltd (086060) - Cash Flow Conversion Efficiency
Based on the latest financial reports, GeneBioTech Co. Ltd (086060) has a cash flow conversion efficiency ratio of 0.072x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩3.87 Billion ≈ $2.62 Million USD) by net assets (₩54.03 Billion ≈ $36.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See GeneBioTech Co. Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
GeneBioTech Co. Ltd - Cash Flow Conversion Efficiency Trend (2009–2024)
This chart illustrates how GeneBioTech Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
GeneBioTech Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of GeneBioTech Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Desoto Resources Ltd
AU:DES
|
-0.226x |
|
OneSavings Bank PLC
LSE:OSB
|
-0.102x |
|
Hove AS
CO:HOVE
|
-0.033x |
|
Sinergi Megah Internusa Tbk PT
JK:NUSA
|
-0.204x |
|
BeLive Holdings Ordinary Share
NASDAQ:BLIV
|
N/A |
|
Planet Green Holdings Corp
NYSE MKT:PLAG
|
0.211x |
|
Quest Resource Holding Corp
NASDAQ:QRHC
|
0.005x |
|
FibroBiologics, Inc. Common Stock
NASDAQ:FBLG
|
-31.776x |
Annual Cash Flow Conversion Efficiency for GeneBioTech Co. Ltd (2009–2024)
The table below shows the annual cash flow conversion efficiency of GeneBioTech Co. Ltd from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see 086060 stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩50.97 Billion ≈ $34.54 Million |
₩-463.87 Million ≈ $-314.36K |
-0.009x | -105.97% |
| 2023-12-31 | ₩48.30 Billion ≈ $32.74 Million |
₩7.37 Billion ≈ $4.99 Million |
0.153x | +289.60% |
| 2022-12-31 | ₩45.73 Billion ≈ $30.99 Million |
₩-3.68 Billion ≈ $-2.49 Million |
-0.080x | -24.45% |
| 2021-12-31 | ₩43.95 Billion ≈ $29.78 Million |
₩-2.84 Billion ≈ $-1.93 Million |
-0.065x | -216.88% |
| 2020-12-31 | ₩45.04 Billion ≈ $30.52 Million |
₩2.49 Billion ≈ $1.69 Million |
0.055x | +196.80% |
| 2019-12-31 | ₩46.93 Billion ≈ $31.80 Million |
₩-2.68 Billion ≈ $-1.82 Million |
-0.057x | -146.02% |
| 2018-12-31 | ₩47.96 Billion ≈ $32.50 Million |
₩5.96 Billion ≈ $4.04 Million |
0.124x | +343.93% |
| 2017-12-31 | ₩40.49 Billion ≈ $27.44 Million |
₩1.13 Billion ≈ $767.40K |
0.028x | -79.46% |
| 2016-12-31 | ₩39.02 Billion ≈ $26.44 Million |
₩5.31 Billion ≈ $3.60 Million |
0.136x | +50.66% |
| 2015-12-31 | ₩28.84 Billion ≈ $19.54 Million |
₩2.61 Billion ≈ $1.77 Million |
0.090x | -1.78% |
| 2014-12-31 | ₩23.42 Billion ≈ $15.87 Million |
₩2.15 Billion ≈ $1.46 Million |
0.092x | -10.63% |
| 2013-12-31 | ₩23.10 Billion ≈ $15.65 Million |
₩2.38 Billion ≈ $1.61 Million |
0.103x | -20.67% |
| 2011-12-31 | ₩19.48 Billion ≈ $13.20 Million |
₩2.53 Billion ≈ $1.71 Million |
0.130x | +104.69% |
| 2010-12-31 | ₩18.38 Billion ≈ $12.45 Million |
₩1.17 Billion ≈ $789.56K |
0.063x | -57.24% |
| 2009-12-31 | ₩18.08 Billion ≈ $12.25 Million |
₩2.68 Billion ≈ $1.82 Million |
0.148x | -- |
About GeneBioTech Co. Ltd
Genebiotech Co., Ltd., a specialized fermentation company, researches, develops, produces, and sells biological resources for use in animal resources, agriculture, food, medicine, etc. It offers functional feed ingredients and additives, as well as veterinary medicines. The company was founded in 1984 and is headquartered in Gongju, South Korea.